Your browser doesn't support javascript.
loading
Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility.
Lellouche, J; Schwartz, D; Elmalech, N; Ben Dalak, M A; Temkin, E; Paul, M; Geffen, Y; Yahav, D; Eliakim-Raz, N; Durante-Mangoni, E; Iossa, D; Bernardo, M; Daikos, G L; Skiada, A; Pantazatou, A; Antoniadou, A; Mouton, J W; Carmeli, Y.
Afiliación
  • Lellouche J; Molecular Epidemiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; National Laboratory for Antibiotic Resistance and Investigation of Outbreaks in Medical Institutions, National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Israel. Electronic addr
  • Schwartz D; Molecular Epidemiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; National Laboratory for Antibiotic Resistance and Investigation of Outbreaks in Medical Institutions, National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Israel.
  • Elmalech N; Molecular Epidemiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; National Laboratory for Antibiotic Resistance and Investigation of Outbreaks in Medical Institutions, National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Israel.
  • Ben Dalak MA; Molecular Epidemiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; National Laboratory for Antibiotic Resistance and Investigation of Outbreaks in Medical Institutions, National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Israel.
  • Temkin E; Molecular Epidemiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; National Laboratory for Antibiotic Resistance and Investigation of Outbreaks in Medical Institutions, National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Israel.
  • Paul M; Institute of Infectious Diseases, Rambam Health Care Campus, Israel; Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
  • Geffen Y; Clinical Microbiology Laboratory, Rambam Health Care Campus, Haifa, Israel.
  • Yahav D; Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv, Israel.
  • Eliakim-Raz N; Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv, Israel; Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
  • Durante-Mangoni E; Department of Precision Medicine, University of Campania 'L Vanvitelli' and AORN dei Colli-Monaldi Hospital, Napoli, Italy.
  • Iossa D; Department of Precision Medicine, University of Campania 'L Vanvitelli' and AORN dei Colli-Monaldi Hospital, Napoli, Italy.
  • Bernardo M; Department of Precision Medicine, University of Campania 'L Vanvitelli' and AORN dei Colli-Monaldi Hospital, Napoli, Italy.
  • Daikos GL; First Department of Medicine, Laikon General Hospital, Greece; National and Kapodistrian University of Athens, Athens, Greece.
  • Skiada A; First Department of Medicine, Laikon General Hospital, Greece; National and Kapodistrian University of Athens, Athens, Greece.
  • Pantazatou A; National and Kapodistrian University of Athens, Athens, Greece; Clinical Microbiology Laboratory, Laikon General Hospital, Greece.
  • Antoniadou A; National and Kapodistrian University of Athens, Athens, Greece; Fourth Department of Medicine, Attikon University General Hospital, Athens, Greece.
  • Mouton JW; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, the Netherlands.
  • Carmeli Y; Molecular Epidemiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; National Laboratory for Antibiotic Resistance and Investigation of Outbreaks in Medical Institutions, National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Israel; Sackler Faculty
Clin Microbiol Infect ; 25(6): 711-716, 2019 Jun.
Article en En | MEDLINE | ID: mdl-30291971
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pruebas de Sensibilidad Microbiana / Tamizaje Masivo / Infecciones por Bacterias Gramnegativas / Colistina / Bacterias Gramnegativas / Antibacterianos Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Screening_studies Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pruebas de Sensibilidad Microbiana / Tamizaje Masivo / Infecciones por Bacterias Gramnegativas / Colistina / Bacterias Gramnegativas / Antibacterianos Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Screening_studies Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2019 Tipo del documento: Article